Qianhai Health Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025

Reuters09-29

<a href="https://laohu8.com/S/00911">Qianhai Health</a> Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025

Qianhai Health Holdings Ltd. reported its unaudited interim results for the six months ended 30 June 2025. The Group recorded revenue of approximately HK$340.9 million, representing an increase of 11% compared to approximately HK$307.0 million for the same period in 2024. Around 99% of the Group's revenue during the period was generated by the Electronic Component Business, which contributed HK$339.1 million. Net profit for the period was HK$4.77 million, compared to HK$15.55 million for the six months ended 30 June 2024. The company noted continued growth in its core business, driven by demand for AI and 5G solutions, and ongoing changes in the automotive sector, while acknowledging ongoing challenges such as supply chain disruptions and pricing pressures. The Group stated that it remains positioned to capitalize on opportunities in the industry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qianhai Health Holdings Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2571886093?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-29 16:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571886093","market":"fut","top_or_hot":-1,"title":"Qianhai Health Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/00911\">Qianhai Health</a> Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Qianhai Health Holdings Ltd. reported its unaudited interim results for the six months ended 30 June 2025. The Group recorded revenue of approximately HK$340.9 million, representing an increase of 11% compared to approximately HK$307.0 million for the same period in 2024. Around 99% of the Group's revenue during the period was generated by the Electronic Component Business, which contributed HK$339.1 million. Net profit for the period was HK$4.77 million, compared to HK$15.55 million for the six months ended 30 June 2024. The company noted continued growth in its core business, driven by demand for AI and 5G solutions, and ongoing changes in the automotive sector, while acknowledging ongoing challenges such as supply chain disruptions and pricing pressures. The Group stated that it remains positioned to capitalize on opportunities in the industry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qianhai Health Holdings Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qianhai Health Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQianhai Health Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-29 16:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/00911\">Qianhai Health</a> Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Qianhai Health Holdings Ltd. reported its unaudited interim results for the six months ended 30 June 2025. The Group recorded revenue of approximately HK$340.9 million, representing an increase of 11% compared to approximately HK$307.0 million for the same period in 2024. Around 99% of the Group's revenue during the period was generated by the Electronic Component Business, which contributed HK$339.1 million. Net profit for the period was HK$4.77 million, compared to HK$15.55 million for the six months ended 30 June 2024. The company noted continued growth in its core business, driven by demand for AI and 5G solutions, and ongoing changes in the automotive sector, while acknowledging ongoing challenges such as supply chain disruptions and pricing pressures. The Group stated that it remains positioned to capitalize on opportunities in the industry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qianhai Health Holdings Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1181","symbol_name":"经销商","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL7p9ptM:1","article_id":"2571886093","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571886093","pubTimestamp":1759135164,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Qianhai Health Holdings Ltd. reported its unaudited interim results for the six months ended 30 June 2025. The Group recorded revenue of approximately HK$340.9 million, representing an increase of 11% compared to approximately HK$307.0 million for the same period in 2024. Around 99% of the Group's revenue during the period was generated by the Electronic Component Business, which contributed HK$339.1 million. Net profit for the period was HK$4.77 million, compared to HK$15.55 million for the six months ended 30 June 2024. The company noted continued growth in its core business, driven by demand for AI and 5G solutions, and ongoing changes in the automotive sector, while acknowledging ongoing challenges such as supply chain disruptions and pricing pressures. The Group stated that it remains positioned to capitalize on opportunities in the industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accur","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1181":"经销商","00911":"前海健康","BK1162":"技术产品经销商"},"translate_title":"前海健康控股有限公司。二零二五年上半年收入增长11%至340,900,000港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00911":0.9},"content_text":"Qianhai Health Holdings Ltd. Reports 11% Rise in Revenue to HK$340.9 Million for First Half of 2025\n    \n\n        Qianhai Health Holdings Ltd. reported its unaudited interim results for the six months ended 30 June 2025. The Group recorded revenue of approximately HK$340.9 million, representing an increase of 11% compared to approximately HK$307.0 million for the same period in 2024. Around 99% of the Group's revenue during the period was generated by the Electronic Component Business, which contributed HK$339.1 million. Net profit for the period was HK$4.77 million, compared to HK$15.55 million for the six months ended 30 June 2024. The company noted continued growth in its core business, driven by demand for AI and 5G solutions, and ongoing changes in the automotive sector, while acknowledging ongoing challenges such as supply chain disruptions and pricing pressures. The Group stated that it remains positioned to capitalize on opportunities in the industry.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qianhai Health Holdings Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2571886093","isCrawlerRequest":true}